 Systemic chemotherapy urothelial cancer patients ureteric obstruction aims study toxicity systemic chemotherapy response rates patients ureteric obstruction urothelial cancer study group patients cisplatin methotrexate upper tract dilatation drainage nephrostomy normal upper tracts response rate patients measurable primary metastatic disease significant differences group group normal group biochemical measurements renal function courses chemotherapy Serious haematological toxicity cycles group cycles normal group complete response rate dilated group normal group increased chemotherapy toxicity patients upper tract dilatation significant complete response rate patients upper tract dilatation renal impairment